STE insider filing: 975 fully vested Career RSUs added to director holdings

Rhea-AI Filing Summary

Christopher S. Holland, a director of STERIS plc (STE), reported the acquisition of 975 Career Restricted Stock Units on 08/08/2025. The filing states these Career RSUs are fully vested immediately and each represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. Following the reported transaction, Mr. Holland beneficially owns 4,964 RSU-linked ordinary shares. The Form 4 was executed by an authorized representative on 08/12/2025.

Positive

• Reporting person acquired 975 Career Restricted Stock Units on 08/08/2025
• The Career RSUs are fully vested immediately, per the filing
• Each RSU represents the right to one ordinary share, with settlement defined (six months after board service cessation)

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director equity award recorded; vested Career RSUs defer settlement until six months after board service ends.

The Form 4 documents a director grant of 975 Career Restricted Stock Units that are noted as fully vested immediately and payable in ordinary shares six months after the director leaves board service. This structure links the award to continued board service termination timing rather than current cash or share transfers. The filing is procedural and discloses the post-termination settlement mechanism and the aggregate beneficial holdings of 4,964 RSU-linked shares.

Securities Analyst

TL;DR: Insider filing shows a modest acquisition of 975 RSUs; disclosed ownership totals and settlement terms are explicit in the Form 4.

The Form 4 reports transaction code 'A' for acquisition of 975 Career RSUs on 08/08/2025, with a reported price of $0 and total beneficial holdings of 4,964 ordinary shares tied to RSUs after the transaction. The disclosure provides clear mechanics for conversion and timing but does not indicate cash proceeds, share sales, or changes to control. From a disclosure perspective the filing is complete for the items reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLLAND CHRISTOPHER S

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 L2 D02 R296

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Career Restricted Stock Units	(1)	08/08/2025		A		975		(2)	(2)	Ordinary Shares	975	$0	4,964	D

Explanation of Responses:

1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Christopher S. Holland report on Form 4 for STERIS (STE)?

He reported the acquisition of 975 Career Restricted Stock Units on 08/08/2025, with beneficial ownership totaling 4,964 RSU-linked ordinary shares after the transaction.

When will the Career RSUs be settled into STERIS (STE) shares?

The filing states each RSU entitles the holder to one ordinary share and will be settled six months after the cessation of the Director's Board service.

Are the Career Restricted Stock Units vested?

Yes. The Form 4 explicitly says the Career RSUs are fully vested immediately.

What was the transaction date and filing signature date on the Form 4?

The transaction date is 08/08/2025, and the Form 4 was signed by an authorized representative on 08/12/2025.

What price was reported for the RSU acquisition on the Form 4?

The Form 4 lists the price as $0 for the Career Restricted Stock Units acquisition.